<?xml version="1.0"?>
<presentation title="09 Nonthalee Pausawasdi" width="720.0000000" height="540.0000000" thmbWidth="78.0000000" thmbHeight="59.0000000" frameRate="24.0000000" looping="0" startingSlideShow="" pptVersion="2010" type="compound" hasExternalAudio="0" uid="{0DC1D269-F443-4211-BB04-F08BF8C735D5}">
	<presenters>
		<presenter name="Nonthalee Pausawasdi" title="Thailand" email="" web="" phone="" photoAssetId="">
			<bio>Are we moving from FNA to FNB?</bio>
		</presenter>
	</presenters>
	<references/>
	<soundAssets>
		<soundAsset id="sndAsset0" src="sound1.mp3" embedded="0" size="498879" duration="17817"/>
		<soundAsset id="sndAsset1" src="sound2.mp3" embedded="0" size="1108159" duration="39577"/>
		<soundAsset id="sndAsset2" src="sound3.mp3" embedded="0" size="1732068" duration="61859"/>
		<soundAsset id="sndAsset3" src="sound4.mp3" embedded="0" size="1142536" duration="40804"/>
		<soundAsset id="sndAsset4" src="sound5.mp3" embedded="0" size="247999" duration="8857"/>
		<soundAsset id="sndAsset5" src="sound6.mp3" embedded="0" size="546422" duration="19515"/>
		<soundAsset id="sndAsset6" src="sound7.mp3" embedded="0" size="1413165" duration="50470"/>
		<soundAsset id="sndAsset7" src="sound8.mp3" embedded="0" size="1626011" duration="58071"/>
		<soundAsset id="sndAsset8" src="sound9.mp3" embedded="0" size="1343679" duration="47988"/>
		<soundAsset id="sndAsset9" src="sound10.mp3" embedded="0" size="2028296" duration="72439"/>
		<soundAsset id="sndAsset10" src="sound11.mp3" embedded="0" size="828022" duration="29572"/>
		<soundAsset id="sndAsset11" src="sound12.mp3" embedded="0" size="1882742" duration="67240"/>
		<soundAsset id="sndAsset12" src="sound13.mp3" embedded="0" size="1704274" duration="60866"/>
		<soundAsset id="sndAsset13" src="sound14.mp3" embedded="0" size="2031222" duration="72543"/>
		<soundAsset id="sndAsset14" src="sound15.mp3" embedded="0" size="1468754" duration="52455"/>
		<soundAsset id="sndAsset15" src="sound16.mp3" embedded="0" size="862399" duration="30799"/>
		<soundAsset id="sndAsset16" src="sound17.mp3" embedded="0" size="3349256" duration="119616"/>
		<soundAsset id="sndAsset17" src="sound18.mp3" embedded="0" size="3879542" duration="138555"/>
	</soundAssets>
	<sharedAssetsLibrary src="assets.swf"/>
	<graphicAssets>
		<graphicAsset id="imgAsset0" src="thmb1.swf" embedded="0"/>
		<graphicAsset id="imgAsset1" src="thmb2.swf" embedded="0"/>
		<graphicAsset id="imgAsset2" src="thmb3.swf" embedded="0"/>
		<graphicAsset id="imgAsset3" src="thmb4.swf" embedded="0"/>
		<graphicAsset id="imgAsset4" src="thmb5.swf" embedded="0"/>
		<graphicAsset id="imgAsset5" src="thmb6.swf" embedded="0"/>
		<graphicAsset id="imgAsset6" src="thmb7.swf" embedded="0"/>
		<graphicAsset id="imgAsset7" src="thmb8.swf" embedded="0"/>
		<graphicAsset id="imgAsset8" src="thmb9.swf" embedded="0"/>
		<graphicAsset id="imgAsset9" src="thmb10.swf" embedded="0"/>
		<graphicAsset id="imgAsset10" src="thmb11.swf" embedded="0"/>
		<graphicAsset id="imgAsset11" src="thmb12.swf" embedded="0"/>
		<graphicAsset id="imgAsset12" src="thmb13.swf" embedded="0"/>
		<graphicAsset id="imgAsset13" src="thmb14.swf" embedded="0"/>
		<graphicAsset id="imgAsset14" src="thmb15.swf" embedded="0"/>
		<graphicAsset id="imgAsset15" src="thmb16.swf" embedded="0"/>
		<graphicAsset id="imgAsset16" src="thmb17.swf" embedded="0"/>
		<graphicAsset id="imgAsset17" src="thmb18.swf" embedded="0"/>
	</graphicAssets>
	<backgroundSound soundAssetId="" looping="0" volume="1.0000000"/>
	<narration>
		<audioTracks>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset0">
				<startTimestamp slideIndex="0" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="0" stepIndex="0" timeOffset="17.7840000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset1">
				<startTimestamp slideIndex="1" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="1" stepIndex="0" timeOffset="39.5400000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset2">
				<startTimestamp slideIndex="2" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="2" stepIndex="0" timeOffset="61.8279991"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset3">
				<startTimestamp slideIndex="3" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="3" stepIndex="0" timeOffset="40.7739983"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset4">
				<startTimestamp slideIndex="4" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="4" stepIndex="0" timeOffset="8.8090000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset5">
				<startTimestamp slideIndex="5" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="5" stepIndex="0" timeOffset="19.4860000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset6">
				<startTimestamp slideIndex="6" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="6" stepIndex="0" timeOffset="50.4169998"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset7">
				<startTimestamp slideIndex="7" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="7" stepIndex="0" timeOffset="58.0250000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset8">
				<startTimestamp slideIndex="8" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="8" stepIndex="0" timeOffset="47.9480000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset9">
				<startTimestamp slideIndex="9" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="9" stepIndex="0" timeOffset="72.4059982"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset10">
				<startTimestamp slideIndex="10" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="10" stepIndex="0" timeOffset="29.5300000"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset11">
				<startTimestamp slideIndex="11" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="11" stepIndex="0" timeOffset="67.1999969"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset12">
				<startTimestamp slideIndex="12" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="12" stepIndex="0" timeOffset="60.8269997"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset13">
				<startTimestamp slideIndex="13" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="13" stepIndex="0" timeOffset="72.5059967"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset14">
				<startTimestamp slideIndex="14" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="14" stepIndex="0" timeOffset="52.4189987"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset15">
				<startTimestamp slideIndex="15" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="15" stepIndex="0" timeOffset="30.7639999"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset16">
				<startTimestamp slideIndex="16" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="16" stepIndex="0" timeOffset="119.5859985"/>
			</audioTrack>
			<audioTrack volume="1.0000000" soundAssetId="sndAsset17">
				<startTimestamp slideIndex="17" stepIndex="0" timeOffset="0.0000000"/>
				<endTimestamp slideIndex="17" stepIndex="0" timeOffset="138.5050000"/>
			</audioTrack>
		</audioTracks>
	</narration>
	<settings>
		<navigation>
			<keyboard enabled="1">
				<actions>
					<action name="playPause">
						<shortcut code="32" control="0" shift="0"/>
					</action>
					<action name="nextSlide">
						<shortcut code="34" control="0" shift="0"/>
					</action>
					<action name="previousSlide">
						<shortcut code="33" control="0" shift="0"/>
					</action>
					<action name="nextStep">
						<shortcut code="13" control="0" shift="0"/>
					</action>
					<action name="previousStep">
						<shortcut code="13" control="0" shift="1"/>
					</action>
					<action name="firstSlide">
						<shortcut code="36" control="1" shift="0"/>
					</action>
					<action name="lastSlide">
						<shortcut code="35" control="1" shift="0"/>
					</action>
					<action name="lastViewedSlide">
						<shortcut code="8" control="0" shift="0"/>
					</action>
					<action name="slideStart">
						<shortcut code="36" control="0" shift="0"/>
					</action>
					<action name="slideEnd">
						<shortcut code="35" control="0" shift="0"/>
					</action>
					<action name="seekForward">
						<shortcut code="39" control="0" shift="0"/>
					</action>
					<action name="seekBackward">
						<shortcut code="37" control="0" shift="0"/>
					</action>
					<action name="volumeUp">
						<shortcut code="38" control="0" shift="0"/>
					</action>
					<action name="volumeDown">
						<shortcut code="40" control="0" shift="0"/>
					</action>
					<action name="toggleFullscreen">
						<shortcut code="70" control="1" shift="0"/>
					</action>
				</actions>
			</keyboard>
			<mouse enabled="1" target="step"/>
			<gesture zoom="1"/>
		</navigation>
		<skin>
			<colorSettings>
				<color id="button.content.normal">#FFFFFF</color>
				<color id="button.content.over">#FFFFFF</color>
				<color id="button.face.normal">#777777</color>
				<color id="button.face.over">#575757</color>
				<color id="companyLogo.background">#FFFFFF</color>
				<color id="hyperlink">#097CE7</color>
				<color id="listItem.face.over">#E8E8E8</color>
				<color id="listItem.face.pressed">#6E6E6E</color>
				<color id="listItem.label.over">#000000</color>
				<color id="listItem.label.pressed">#FFFFFF</color>
				<color id="listItem.label.visited">#A1A1A1</color>
				<color id="page.background">#8A8A8A</color>
				<color id="panel.background">#F7F7F7</color>
				<color id="panel.text">#323232</color>
				<color id="player.background">#D4D4D4</color>
				<color id="popup.background">#FFFFFF</color>
				<color id="progress.background">#6E6E6E</color>
				<color id="progress.loading">#D0D0D0</color>
				<color id="progress.playback">#A1A1A1</color>
				<color id="text">#4D4D4D</color>
			</colorSettings>
			<controlPanelSettings>
				<visible>true</visible>
				<showOutline>false</showOutline>
				<showPlayPause>true</showPlayPause>
				<showRewind>true</showRewind>
				<showVolumeControl>true</showVolumeControl>
				<showCCButton>false</showCCButton>
				<showPrevButton>true</showPrevButton>
				<showNextButton>true</showNextButton>
				<showSlideOnlyButton>true</showSlideOnlyButton>
				<progressBar>
					<visible>true</visible>
					<enabled>true</enabled>
					<showLabels>true</showLabels>
					<mode>slideTimeline</mode>
				</progressBar>
				<navigationMode>bySlides</navigationMode>
			</controlPanelSettings>
			<titlePanelSettings>
				<showLogo>false</showLogo>
				<visible>true</visible>
				<buttons>
					<button type="attachments" visible="false"/>
					<button type="presenterInfo" visible="false"/>
					<button type="markerTools" visible="true"/>
					<button type="notes" visible="false"/>
					<button type="outline" visible="false"/>
				</buttons>
			</titlePanelSettings>
			<outlinePanelSettings>
				<numberEntries>true</numberEntries>
				<highlightViewedEntries>true</highlightViewedEntries>
				<thumbnails>true</thumbnails>
				<search>true</search>
				<multilevel>true</multilevel>
			</outlinePanelSettings>
			<sidePanelSettings>
				<showAtLeft>true</showAtLeft>
				<showLogo>false</showLogo>
				<showPresenterInfo>true</showPresenterInfo>
				<showPresenterVideo>false</showPresenterVideo>
				<visible>true</visible>
				<tabsPanel>
					<showOutline>true</showOutline>
					<showNotes>false</showNotes>
				</tabsPanel>
			</sidePanelSettings>
		</skin>
		<appearance fullScreen="1" showSlidePreloader="1"/>
		<playback autoStart="1" syncWithVideoNarration="1" enableVideoControl="1" resumePresentationPlayback="always"/>
	</settings>
	<slides embedded="0">
		<slide index="0" title="Are we moving from FNA to FNB?" titleNormalized="are we moving from fna to fnb?" src="slide1.swf" size="452142" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset0" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="17.7830004"/>
			</animationSteps>
			<notes/>
			<notesNormalized/>
			<notesHtml/>
			<text>Are we moving from FNA to FNB?
Nonthalee Pausawasdi, MD.
Faculty of Medicine Siriraj Hospital
Mahidol University, Thailand</text>
		</slide>
		<slide index="1" title="Evolution of needle design for EUS-guided tissue acquisition (TA)" titleNormalized="evolution of needle design for eus-guided tissue acquisition (ta)" src="slide2.swf" size="15229" advanceOnTime="1" framesCount="661" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset1" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="660" playTime="27.5000000" pauseTime="12.0400009"/>
			</animationSteps>
			<notes/>
			<notesNormalized/>
			<notesHtml/>
			<text>Evolution of needle design for EUS-guided tissue acquisition (TA)
Early 2000s’ Now
Up to 2000
Various kinds of needles
Needle
Tru-cut
(Quick-Core)
Reverse bevel
(ProCore)
Fork-tip
(SharkCore)
Franseen
(Acquire)
Forward bevel
(ProCore)
Size
 19-25 G 19 G 19,22,25 G 19,22,25 G 22,25 G 20G
 1st-generation 2nd-generation 3rd-generation
 ROSE
No ROSE if adequate sample
Role of ROSE?
Drawback: 
Lack of tissue architecture
Availability of ROSE
</text>
		</slide>
		<slide index="2" title="Evolution of needle design for EUS-guided tissue acquisition (TA)" titleNormalized="evolution of needle design for eus-guided tissue acquisition (ta)" src="slide3.swf" size="14620" advanceOnTime="1" framesCount="272" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset2" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="271" playTime="11.2916667" pauseTime="50.5363324"/>
			</animationSteps>
			<notes/>
			<notesNormalized/>
			<notesHtml/>
			<text>Evolution of needle design for EUS-guided tissue acquisition (TA)
Early 2000s’ Now
Up to 2000
Various kinds of needles
Needle
Tru-cut
(Quick-Core)
Reverse bevel
(ProCore)
Fork-tip
(SharkCore)
Franseen
(Acquire)
Forward bevel
(ProCore)
Size
 19-25 G 19 G 19,22,25 G 19,22,25 G 22,25 G 20G
 1st-generation 2nd-generation 3rd-generation
 ROSE
No ROSE needed in large volume ctr
Role of ROSE ?</text>
		</slide>
		<slide index="3" title="What needs to be considered before replacing FNA with FNB?" titleNormalized="what needs to be considered before replacing fna with fnb?" src="slide4.swf" size="2009" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset3" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="40.7729983"/>
			</animationSteps>
			<notes>Now, I’d like to draw your attention to the currently available evidence in regard to biopsy needle. FNA with cytologic analysis has been an excellent tool for tissue diagnosis of GI lesions but its major drawback is lack of tissue architecture limiting the ability to diagnose certain conditions. To overcome this problem, biopsy needles have been developed in order to obtain core tissue. Ideally, for biopsy needle to replace FNA, it has to have at least comparable technical perfoamce, provide better tissue adequacy, better accuracy, equally safe and cost effective.</notes>
			<notesNormalized>now, i’d like to draw your attention to the currently available evidence in regard to biopsy needle. fna with cytologic analysis has been an excellent tool for tissue diagnosis of gi lesions but its major drawback is lack of tissue architecture limiting the ability to diagnose certain conditions. to overcome this problem, biopsy needles have been developed in order to obtain core tissue. ideally, for biopsy needle to replace fna, it has to have at least comparable technical perfoamce, provide better tissue adequacy, better accuracy, equally safe and cost effective.</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;Now, I’d like to draw your attention to the currently available evidence in regard to biopsy needle. FNA with cytologic analysis has been an excellent tool for tissue diagnosis of GI lesions but its major drawback is lack of tissue architecture limiting the ability to diagnose certain conditions. To overcome this problem, biopsy needles have been developed in order to obtain core tissue. Ideally, for biopsy needle to replace FNA, it has to have at least comparable technical perfoamce, provide better tissue adequacy, better accuracy, equally safe and cost effective.&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>Equally good or better technical performance
Better tissue adequacy/quality WITHOUT ROSE 
(Less time consuming)
Higher diagnostic accuracy
 Equally Safe
 Cost-effective
What needs to be considered before replacing FNA with FNB?</text>
		</slide>
		<slide index="4" title="What is the evidence comparing FNA &amp; FNB?" titleNormalized="what is the evidence comparing fna &amp; fnb?" src="slide5.swf" size="2327" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset4" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="8.8090004"/>
			</animationSteps>
			<notes>Now, I’d like to draw your attention to the currently available evidence in regard to biopsy needle. FNA with cytologic analysis has been an excellent tool for tissue diagnosis of GI lesions but its major drawback is lack of tissue architecture limiting the ability to diagnose certain conditions. To overcome this problem, biopsy needles have been developed in order to obtain core tissue. Ideally, for biopsy needle to replace FNA, it has to have at least comparable technical perfoamce, provide better tissue adequacy, better accuracy, equally safe and cost effective.</notes>
			<notesNormalized>now, i’d like to draw your attention to the currently available evidence in regard to biopsy needle. fna with cytologic analysis has been an excellent tool for tissue diagnosis of gi lesions but its major drawback is lack of tissue architecture limiting the ability to diagnose certain conditions. to overcome this problem, biopsy needles have been developed in order to obtain core tissue. ideally, for biopsy needle to replace fna, it has to have at least comparable technical perfoamce, provide better tissue adequacy, better accuracy, equally safe and cost effective.</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;Now, I’d like to draw your attention to the currently available evidence in regard to biopsy needle. FNA with cytologic analysis has been an excellent tool for tissue diagnosis of GI lesions but its major drawback is lack of tissue architecture limiting the ability to diagnose certain conditions. To overcome this problem, biopsy needles have been developed in order to obtain core tissue. Ideally, for biopsy needle to replace FNA, it has to have at least comparable technical perfoamce, provide better tissue adequacy, better accuracy, equally safe and cost effective.&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>Technical performance of needle
Tissue adequacy/
quality
Diagnostic accuracy
Safety
Cost-effective
Without ROSE
What is the evidence comparing FNA &amp; FNB? 
Yes</text>
		</slide>
		<slide index="5" title="4 Meta-analysis comparing FNA vs FNB" titleNormalized="4 meta-analysis comparing fna vs fnb" src="slide6.swf" size="4714" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset5" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="19.4850001"/>
			</animationSteps>
			<notes/>
			<notesNormalized/>
			<notesHtml/>
			<text>4 Meta-analysis comparing FNA vs FNB 
Aadam AA, Amick AE, Shah JN, et al. Gastrointest Endosc. 2014;79:AB188–9.
Study
N
(total)
Lesions
Compared needle &amp;
specimen type
Diagnostic accuracy
Other outcomes
Bang, 2016
576
Various masses, LN
Procore vs FNA 22,25

NSD for overall and panc mass
FNB: fewer passes
Oh, 2016
896
various masses,
LN
Procore vs FNA 22,25

NSD for overall
FNB: better in panc mass &amp; histo core
Khan, 2017
1024
SEL&gt;2cm
Procore 22 vs FNA 22

NSD
FNB: fewer passes
Wang, 2017
921
(8RCT)
Solid panc mass
Procore 22 vs FNA 22

NSD
FNB: better adequacy, fewer passes
+13 RCTs comparing FNA vs FNB (2012-2017): 
Results: NSD for diagnosis, FNB offers better histology quality with fewer passes</text>
		</slide>
		<slide index="6" title="" titleNormalized="" src="slide7.swf" size="70478" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset6" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="50.4159998"/>
			</animationSteps>
			<notes>It was thought that the reason for not seeing the differences had to do with small sample size. Therefore, this multicenter RCT from China was conducted.</notes>
			<notesNormalized>it was thought that the reason for not seeing the differences had to do with small sample size. therefore, this multicenter rct from china was conducted.</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;It was thought that the reason for not seeing the differences had to do with small sample size. Therefore, this multicenter RCT from China was conducted.&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>Aadam AA, Amick AE, Shah JN, et al. Gastrointest Endosc. 2014;79:AB188–9.
Outcomes
(N=377)
FNB (N=190)
(procore 22)
FNA (N=187)
(Echotip 22)
P value
Overall diagnostic accuracy
91%
80%
0.0015
Pancreatic mass : Histology
(N=249)
93%
82%
0.0099
Pancreatic mass : Cytology
89%
79%
0.0047
Non-pancreatic lesions
similar
similar
NS</text>
		</slide>
		<slide index="7" title="Prospective assessment of the diagnostic performance of EUS-FNB (Acquire 22G) in abdominal masses (N=100) without ROSE" titleNormalized="prospective assessment of the diagnostic performance of eus-fnb (acquire 22g) in abdominal masses (n=100) without rose" src="slide8.swf" size="75081" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset7" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="58.0240015"/>
			</animationSteps>
			<notes/>
			<notesNormalized/>
			<notesHtml/>
			<text>CA gallbladder
1.7%
Spindle cell tumor
1.7%
Neuroendocrine tumor (NET)
1.7%
Lymphoma
1.7%
Leiomyoma
1.7%
Disseminated cryptococcosis
1.7%
Atypical cell
1.7%
Epitheloid cell aggregation
1.7%
Other (13%)
Prospective assessment of the diagnostic performance of EUS-FNB (Acquire 22G) in abdominal masses (N=100) without ROSE
DDW 2018</text>
		</slide>
		<slide index="8" title="Diagnostic Performance of EUS-FNB for solid masses (n=100)" titleNormalized="diagnostic performance of eus-fnb for solid masses (n=100)" src="slide9.swf" size="5403" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset8" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="47.9470019"/>
			</animationSteps>
			<notes>	Overall diagnostic performance of EUS-FNB ในการวินิจฉัย solid intra-abdominal mass had a sensitivity of 88.1% (95% CI,77.1-95.1), specificity of 100% (95% CI, 2.5-100), positive predictive value (PPV) of 100% (95% CI,93.2-100), negative predictive value (NPV) of 12.5% (95% CI,0.3-52.7), the area under the receiver operating curve (AUROC) of 0.941 (95% CI,0.851-1.000) with the accuracy of 88.3%. For detection of malignancy, FNB had a sensitivity of 97.7% (95% CI,87.7-99.9), specificity of 90% (95% CI, 55.5-99.7), positive predictive value (PPV) of 97.7% (95% CI,87.7-99.9), negative predictive value (NPV) of 90% (95% CI,55.5-99.7), the area under the receiver operating curve (AUROC) of 0.938 (95% CI,0.826-1.000) with the accuracy of 96.2%. </notes>
			<notesNormalized>	overall diagnostic performance of eus-fnb ในการวินิจฉัย solid intra-abdominal mass had a sensitivity of 88.1% (95% ci,77.1-95.1), specificity of 100% (95% ci, 2.5-100), positive predictive value (ppv) of 100% (95% ci,93.2-100), negative predictive value (npv) of 12.5% (95% ci,0.3-52.7), the area under the receiver operating curve (auroc) of 0.941 (95% ci,0.851-1.000) with the accuracy of 88.3%. for detection of malignancy, fnb had a sensitivity of 97.7% (95% ci,87.7-99.9), specificity of 90% (95% ci, 55.5-99.7), positive predictive value (ppv) of 97.7% (95% ci,87.7-99.9), negative predictive value (npv) of 90% (95% ci,55.5-99.7), the area under the receiver operating curve (auroc) of 0.938 (95% ci,0.826-1.000) with the accuracy of 96.2%.</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;	Overall diagnostic performance of EUS-FNB ในการวินิจฉัย solid intra-abdominal mass had a sensitivity of 88.1% (95% CI,77.1-95.1), specificity of 100% (95% CI, 2.5-100), positive predictive value (PPV) of 100% (95% CI,93.2-100), negative predictive value (NPV) of 12.5% (95% CI,0.3-52.7), the area under the receiver operating curve (AUROC) of 0.941 (95% CI,0.851-1.000) with the accuracy of 88.3%. For detection of malignancy, FNB had a sensitivity of 97.7% (95% CI,87.7-99.9), specificity of 90% (95% CI, 55.5-99.7), positive predictive value (PPV) of 97.7% (95% CI,87.7-99.9), negative predictive value (NPV) of 90% (95% CI,55.5-99.7), the area under the receiver operating curve (AUROC) of 0.938 (95% CI,0.826-1.000) with the accuracy of 96.2%. &lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>PPV: positive predictive value, NPV: negative predictive value, CI: confidence interval, 
AUROC: Area under Receiver-Operating Characteristics curve

Diagnostic Performance of EUS-FNB for solid masses (n=100)</text>
		</slide>
		<slide index="9" title="Comparison of diagnostic performance of FNB (histology) and historical controlled FNA (N=166, cytology with cell block)" titleNormalized="comparison of diagnostic performance of fnb (histology) and historical controlled fna (n=166, cytology with cell block)" src="slide10.swf" size="4589" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset9" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="72.4049982"/>
			</animationSteps>
			<notes/>
			<notesNormalized/>
			<notesHtml/>
			<text>Comparison of diagnostic performance of FNB (histology) and historical controlled FNA (N=166, cytology with cell block)</text>
		</slide>
		<slide index="10" title="Comparison of tissue adequacy of FNB and FNA (historical control, N=166)" titleNormalized="comparison of tissue adequacy of fnb and fna (historical control, n=166)" src="slide11.swf" size="2385" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset10" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="29.5290007"/>
			</animationSteps>
			<notes/>
			<notesNormalized/>
			<notesHtml/>
			<text>Comparison of tissue adequacy of FNB and FNA (historical control, N=166)</text>
		</slide>
		<slide index="11" title="" titleNormalized="" src="slide12.swf" size="96992" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset11" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="67.1989969"/>
			</animationSteps>
			<notes>In contrast to our study, a large retrospective study recruiting over 3,000….. Study is different from ours.</notes>
			<notesNormalized>in contrast to our study, a large retrospective study recruiting over 3,000….. study is different from ours.</notesNormalized>
			<notesHtml>&lt;p&gt;&lt;font size="12"&gt;In contrast to our study, a large retrospective study recruiting over 3,000….. Study is different from ours.&lt;/font&gt;&lt;/p&gt;</notesHtml>
			<text>Retrospective analysis of 3,020 patients 
(FNA 69%, FNB 31%- 22 G Acquire with ROSE)</text>
		</slide>
		<slide index="12" title="Comparison between different FNB" titleNormalized="comparison between different fnb" src="slide13.swf" size="52103" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset12" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="60.8259997"/>
			</animationSteps>
			<notes/>
			<notesNormalized/>
			<notesHtml/>
			<text>Comparison between different FNB
Nayar, 2017
Abdelfatah, 
2017
Bang, 2017
Park, 2017
Results:
Procore- 22 &amp; 25G: comparable 
 - forward-bevel superior to reverse-bevel
Franseen vs Fork tip: comparable</text>
		</slide>
		<slide index="13" title="What is comping up next for FNB in 2019?" titleNormalized="what is comping up next for fnb in 2019?" src="slide14.swf" size="126827" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset13" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="72.5049967"/>
			</animationSteps>
			<notes/>
			<notesNormalized/>
			<notesHtml/>
			<text>What is comping up next for FNB in 2019?</text>
		</slide>
		<slide index="14" title="" titleNormalized="" src="slide15.swf" size="79906" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset14" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="52.4179987"/>
			</animationSteps>
			<notes/>
			<notesNormalized/>
			<notesHtml/>
		</slide>
		<slide index="15" title="" titleNormalized="" src="slide16.swf" size="198316" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset15" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="30.7629999"/>
			</animationSteps>
			<notes/>
			<notesNormalized/>
			<notesHtml/>
		</slide>
		<slide index="16" title="Current status: FNA vs FNB" titleNormalized="current status: fna vs fnb" src="slide17.swf" size="48408" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset16" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="119.5849985"/>
			</animationSteps>
			<notes/>
			<notesNormalized/>
			<notesHtml/>
			<text>Current status: FNA vs FNB
 Now
 2020 onwards
FNA-
FNB
Technical performance of needle
Comparable
Comparable
Tissue adequacy/quality
Inferior 
Superior
Diagnostic accuracy
Better in pancreatic cancer
Safety
Comparable

Comparable

Cost
Comparable to FNB in US (other regions not known) 
Comparable to FNA in US (other regions not known) 

Lots of on-going research (clinical trial.gov)

49 trials 
34 RCTs
Comparing FNA vs FNB
Comparing FNB vs FNB (different kinds)
ROSE vs NO ROSE
Population: pancreatic ca, GIST, lymphoma, solid lesions

FNB definitely has a role in molecular profiling




FNB</text>
		</slide>
		<slide index="17" title="Proposed “tailored approach” for needle selection" titleNormalized="proposed “tailored approach” for needle selection" src="slide18.swf" size="75751" advanceOnTime="1" framesCount="1" hasEmbeddedFlashClip="0" hidden="0" level="0" advanceOnClick="1" thumbnailAssetId="imgAsset17" presenterIndex="0">
			<sounds/>
			<videos/>
			<transitionEffect name="" duration="0.0000000" soundId="" looped="0"/>
			<soundCommands/>
			<videoCommands/>
			<animationSteps>
				<step start="0" end="0" playTime="0.0010000" pauseTime="138.5040049"/>
			</animationSteps>
			<notes/>
			<notesNormalized/>
			<notesHtml/>
			<text>Proposed “tailored approach” for needle selection
Conclusion</text>
		</slide>
	</slides>
</presentation>
